X4 Pharmaceuticals Inc (XFOR) stock news · rev $6.5M
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
This XFOR news page leads with what X4 Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for XFOR yet. We will not pad this page with generic market recap.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 150.0% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the XFOR stock page; for the tape open the quote page.
XFOR stock news FAQ
What are XFOR's latest revenue and net income?
Latest cached X4 Pharmaceuticals Inc (XFOR) revenue for Dec 31, 2025 was $6.5M. Net income was -$79.2M. Statements: https://lician.com/financials/xfor
How did XFOR revenue change from the prior cached period?
Cached X4 Pharmaceuticals Inc (XFOR) revenue was up 150.0% from $2.6M (Dec 31, 2024) to $6.5M (Dec 31, 2025). Statements: https://lician.com/financials/xfor
What is XFOR's market cap?
X4 Pharmaceuticals Inc (XFOR) market cap is $382.0M on the latest cached fundamentals snapshot.
What kind of company is XFOR?
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Where is XFOR stock news listed?
Cached stock news for X4 Pharmaceuticals Inc (XFOR) is listed at https://lician.com/news/xfor. Filings: https://lician.com/sec/xfor
Not investment advice.